Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: HPGCD

November 30, 2021 CD derivatives / Life sciences

Cyclodextrins Exert a Ligand-like Current Inhibitory Effect on the KV1.3 Ion Channel Independent of Membrane Cholesterol Extraction

Effects of CDs exerted on cellular functions are generally thought to originate from reductions in cholesterol levels. Potential direct, ligand-like

Continue reading

July 12, 2021 Drug delivery / Pharma applications

Nanofibrous Formulation of Cyclodextrin Stabilized Lipases for Efficient Pancreatin Replacement Therapies

The purpose of enzyme therapies (ERT) is simple: patients who suffer from enzyme deficiency should be treated by administering enzymes

Continue reading

March 4, 2020 Food

Fast-dissolving antioxidant curcumin/cyclodextrin inclusion complex electrospun nanofibrous webs

Curcumin/Hydroxypropyl-beta-Cyclodextrin (HP-β-CD) and Curcumin/Hydroxypropyl-gamma-Cyclodextrin (HP-γ-CD) inclusion complex nanofibrous webs were produced using electrospinning technique for the purpose of orally fast-dissolving

Continue reading

January 15, 2019 Drug delivery

Antibiotics degradation products against Alzheimer’s disease

A recent paper in Cell Reports published an interesting finding: polymeric degradation products (compound X and Z, respectively) of antibiotics

Continue reading

August 30, 2018 CD as API / Pharma applications

Different cyclodextrins to treat NPC

If you are following advances in the re-discovery of cyclodextrins as APIs, there is quite a race among the candidates

Continue reading

Posts pagination

«Previous Posts 1 2

Recent Posts

  • Events of American Cyclodextrin Consortium
  • Ultrafast-dissolving ocular microneedle patch with voriconazole-cyclodextrin complex
  • Nano-Enabled Toxicity of Pharmaceutical Excipients
  • Cyclodextrins Across the Eye-Care Spectrum
  • Biphasic dissolving microneedles with cyclodextrin inclusion complexes for enhanced delivery of poorly soluble drugs

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (66)
  • CD as API (347)
  • CD derivatives (410)
  • Cosmetics and toilettry (51)
  • Diagnosis (12)
  • Drug delivery (790)
  • E-ducation (63)
  • Environmental (134)
  • Events (234)
  • Food (221)
  • Gene delivery (20)
  • Household products (4)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (42)
  • Non-pharma applications (399)
  • Other industrial use (106)
  • Pharma applications (1,182)
  • Supramolecular systems (40)
  • Uncategorized (146)

Top Posts

  • Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions
  • Events of American Cyclodextrin Consortium
  • Ultrafast-dissolving ocular microneedle patch with voriconazole-cyclodextrin complex
  • Using cyclodextrin is not rocket science...except for NASA researchers.
  • HPαCD Therapy: A Breakthrough for Krabbe Disease Treatment
  • FDA Grants Approval to HPBCD-Enhanced Biologic: A 'Super-Originator' Formulation
  • Lanosterol eye drops for cataract treatment
  • Bridion® injection now approved for patients of all ages
  • Febreeze with double HPBCD concentration for kitchen smell
  • CD-enabled active food packaging in the recent literature

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,472 other subscribers

Loading Comments...